Effect of dietary composition of weight loss diets on high-sensitivity C-reactive protein: The randomized POUNDS LOST trial

Obesity

Volumn 21, Issue 4, 2013, Pages 681-689

  Nicklas, Jacinda M ^a,b   Sacks, Frank M ^c   Smith, Steven R ^d   Leboff, Meryl S ^b   Rood, Jennifer C ^e   Bray, George A ^e   Ridker, Paul M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BURNHAM INSTITUTE   (United States)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY FAT; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FATTY LIVER; FEMALE; HUMAN; LIPID DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PROTEIN DIET; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADIPOSITY; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CHOLESTEROL; DIET, REDUCING; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; FASTING; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; WAIST CIRCUMFERENCE;

EID: 84878327674     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20072     Document Type: Article

References (40)

1. Nguyen XM, Lane J, Smith BR, Nguyen NT,. Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. J Gastrointest Surg 2009; 13: 1205-1212.
2. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
3. Selvin E, Paynter NP, Erlinger TP,. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 2007; 167: 31-39.
4. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
5. Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS,. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA 2004; 292: 2482-2490.
6. Pittas AG, Roberts SB, Das SK, et al. The effects of dietary glycemic load on type 2 diabetes risk factors during weight loss. Obesity 2006; 14: 2200-2209.
7. Rankin JW, Turpyn AD,. Low carbohydrate, high fat diet increases C-reactive protein during weight loss. J Am Coll Nutr 2007; 26: 163-169.
8. O'Brien KD, Brehm BJ, Seeley RJ, et al. Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab 2005; 90: 2244-2249.
9. Noakes M, Foster PR, Keogh JB, James AP, Mamo JC, Clifton PM,. Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk. Nutr Metab 2006; 3: 7.
10. Tay J, Brinkworth GD, Noakes M, Keogh J, Clifton PM,. Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J Am Coll Cardiol 2008; 51: 59-67.
11. Brinkworth GD, Noakes M, Buckley JD, Keogh JB, Clifton PM,. Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr 2009; 90: 23-32.
12. Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors. Ann Int Med 2006; 145: 1-11.
13. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Eng J Med 2009; 360: 859-873.
14. American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114: 82-96.
15. Dansinger ML, Gleason JA, Griffith JL, Selker JP, Schaefer EJ,. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005; 293: 43-53.
16. Gardner CD, Kiazand A, Alhassan S, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A to Z Weight Loss Study: a randomized trial. JAMA 2007; 297: 969-977. [Erratum, JAMA 2007;298:178.]
17. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J,. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999; 281: 1505-1511.
18. Kvist H, Chowdhury B, Grangard U, Tylen U, Sjostrom L,. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988; 48: 1351-1361.
19. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized controlled trial. JAMA 2003; 289: 1799-1804.
20. Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008; 359: 229-241.
21. Haffner S, Temprosa M, Crandall J, et al. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 2005; 54: 1566-1572.
22. Belacazar LM, Reboussin DM, Haffner SM, et al. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 2010; 33: 2297-2303.
23. Laimer M, Ebenbichler CF, Kaser S, et al. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes 2002; 26: 659-662.
24. Cugno M, Castelli R, Mari D, et al. Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding. Intern Emerg Med 2012; 7: 237-242.
25. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW,. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
26. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM,. Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation 2000; 102: 42-47.
27. Beasley LE, Koster A, Newman AB, et al. Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity 2009; 17: 1062-1069.
28. Park HS, Park JY, Yu R,. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 2005; 69: 29-35.
29. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007; 116: 1234-1241.
30. Piche ME, Lemieux S, Weisnagel SJ, et al. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005; 96: 92-97.
31. Fisher G, Hyatt TC, Hunter GR, Oster RA, Desmond RA, Gower BA,. Effect of diet with and without exercise training on markers of inflammation and fat distribution in overweight women. Obesity 2011; 19: 1131-1136.
32. McKimmie RL, Daniel KR, Carr JJ, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 2008; 103: 3029-3035.
33. Zimmerman E, Anty R, Tordjman J, et al. C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. J Hepatol 2011; 55: 660-665.
34. Goodpaster BH, DeLany JP, Otto AD, et al. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults. JAMA 2010; 304: 1795-1802.
35. Larson-Meyer DE, Newcomer BR, Heilbronn LK, et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity 2008; 16: 1355-1362.
36. Gögebakan O, Kohl A, Osterhoff MA, et al. Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial. Circulation 2011; 124: 2829-2838.
37. Rizkalla SW, Prifti E, Cotillard A, et al. Differential effects of macronutrient content in 2 energy-restricted diets on cardiovascular risk factors and adipose tissue cell size in moderately obese individuals: a randomized controlled trial. Am J Clin Nutr 2012; 95: 49-63.
38. Clément K, Viguerie N, Poitou C, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18: 1657-1669.
39. Giugliano D, Ceriello A, Esposito K,. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006; 48: 677-685.
40. Church TS, Earnest CP, Thompson AM, et al. Exercise without weight loss does not reduce C-reactive protein: the INFLAME study. Med Sci Sports Exerc 2010; 42: 708-716.